After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Read full article: KP George KO’d in primary race for reelection as Fort Bend County Judge Read full article: Suspect turns self in after allegedly stabbing man during argument Keeping your pets happy ...

(Reuters) -Germany's Merck KGaA on Thursday said it had struck a deal with U.S. President Donald Trump that would cut the cost of some drugs needed for an in-vitro fertilization treatment cycle. The ...

(RTTNews) - Merck KGaA (MKKGY) announced that its U.S. and Canadian healthcare division, EMD Serono, has entered into an agreement with President Donald J. Trump's administration to broaden access to ...

Please provide your email address to receive an email when new articles are posted on . Merck KGaA will lower the costs of its IVF drugs by up to 84%. Patients will be able to purchase the drugs ...

CARLSBAD, Calif., July 16, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE - News) today announced that the company has signed an agreement to collaborate with Merck Serono, a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Waltham-based biotech startup Provenance Biopharmaceuticals ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma's new chronic ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Pharmaceutical giant Merck is buying Verona ...